- Latest available (Revised)
- Point in Time (26/03/2021)
- Original (As made)
Point in time view as at 26/03/2021.
There are currently no known outstanding effects for the The Human Tissue (Authorisation) (Specified Type A Procedures) (Scotland) Regulations 2020.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Scottish Statutory Instruments
Human Tissue
Made
12th March 2020
Coming into force in accordance with regulation 1
The Scottish Ministers make the following Regulations in exercise of the powers conferred by sections 16B(1) and (2) of the Human Tissue (Scotland) Act 2006 M1 and all other powers enabling them to do so.
In accordance with section 16B(4) of that Act they have consulted with such persons as they consider appropriate.
In accordance with section 59(3)(ad) M2 of that Act, a draft of this instrument has been laid before and approved by resolution of the Scottish Parliament.
Marginal Citations
M12006 asp. 4. Section 16B was inserted by section 23(1) of the Human Tissue (Authorisation) (Scotland) Act 2019 asp 11 (“the 2019 Act”).
M2Section 59(3)(ad) was inserted by 23(2) of the 2019 Act.
1. These Regulations may be cited as the Human Tissue (Authorisation) (Specified Type A Procedures) (Scotland) Regulations 2020 and come into force on the day on which section 23 of the Human Tissue (Authorisation) (Scotland) Act 2019 M3 comes into force for all purposes.
Commencement Information
I1Reg. 1 in force at 26.3.2021, see reg. 1; S.S.I. 2021/108, reg. 2
Marginal Citations
2. The pre-death procedures specified in the second column of the table in the schedule are specified as Type A procedures for the purposes of sections 16D to 16F of the Human Tissue (Scotland) Act 2006 M4.
Commencement Information
I2Reg. 2 in force at 26.3.2021, see reg. 1; S.S.I. 2021/108, reg. 2
Marginal Citations
M4Sections 16D to 16F were inserted by section 23(1) of the 2019 Act.
JOE FITZPATRICK
Authorised to sign by the Scottish Ministers
St Andrew's House,
Edinburgh
Regulation 2
1. In this schedule—S
“arterial line” means a cannula inserted into an artery,
“blood component” means any of the following constituents of human blood—
red cells,
white cells,
platelets, and
plasma,
“blood product” means any therapeutic product derived from human blood or plasma,
“intravenous fluids” means any electrolyte solution intended for intravenous administration,
“pre-established airway and ventilatory support” means any method of airway or ventilatory support administered to the person for the primary purpose of the person's medical treatment prior to any decision to withdraw life sustaining treatment,
“pre-established suprapubic catheter” means a suprapubic catheter inserted into the person for the primary purpose of the person's medical treatment prior to any decision to withdraw life sustaining treatment.
Class of procedure | Type of procedure |
---|---|
Collection of bodily fluids and microbiological samples | Taking of a blood sample |
Taking of a urine sample including by way of a pre-established suprapubic catheter | |
Taking of a chest secretion sample (excluding bronchoscopy) | |
Swabbing or scraping of the body including inside of the mouth, nostril or ear canal but excluding the swabbing or scraping of any part of any other body orifice | |
Radiological imaging | Carrying out of an X-Ray without transferring the person from their existing location |
Carrying out of ultrasound imaging without transferring the person from their existing location | |
Carrying out of transthoracic echocardiography without transferring the person from their existing location | |
Cardiovascular monitoring | Carrying out of electrocardiogram |
Cardiac output monitoring by way of an arterial line | |
Carrying out of central venous pressure monitoring | |
Arterial blood pressure monitoring including by way of an arterial line | |
Respiratory monitoring and support | Measuring of oxygen saturation |
Sustaining the appropriate operation of any pre-established airway and ventilatory support | |
Administration of medication or other product | Administration of antimicrobials |
Administration of intravenous fluids | |
Administration of medication to manage blood pressure | |
Administration of blood, blood components and blood products |
Commencement Information
I3Sch. para. 1 in force at 26.3.2021, see reg. 1; S.S.I. 2021/108, reg. 2
(This note is not part of the Regulations)
These Regulations specify medical procedures which may be carried out on a person for the purpose of increasing the likelihood of successful transplantation of a part of the person's body after the person's death and which are not for the primary purpose of safeguarding or promoting the physical or mental health of the person, known under the Human Tissue (Scotland) Act 2006 (“the Act”) as “pre-death procedures” (see section 16A inserted by section 23 of the Human Tissue (Authorisation) (Scotland) Act 2019).
These Regulations specify the “Type A procedures”. Type A procedures are those pre-death procedures which Ministers consider are appropriate to be carried out in accordance with section 16E of the Act without the need for further conditions or restrictions on their performance such as only in specified circumstances or following further authorisation.
A pre-death procedure may only be carried out on a person if it has been specified as either a Type A procedure or Type B procedure (see section 16D of the Act).
No business and regulatory impact assessment has been prepared for these Regulations as no impact upon business, charities or voluntary bodies is foreseen.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Policy Note sets out a brief statement of the purpose of a Scottish Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Scottish Statutory Instrument accessible to readers who are not legally qualified and accompany any Scottish Statutory Instrument or Draft Scottish Statutory Instrument laid before the Scottish Parliament from July 2012 onwards. Prior to this date these type of notes existed as ‘Executive Notes’ and accompanied Scottish Statutory Instruments from July 2005 until July 2012.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: